TMC114-C211: Trial of an Investigational Protease Inhibitor TMC114 With Ritonavir ("TMC114/r") in HIV-1 Infected Patients Who Have Never Been Treated With Antiretroviral Medications.
Clinical trial NCT00258557 · COMPLETED
Trial details
- NCT number
- NCT00258557
- Sponsor
- Tibotec Pharmaceuticals, Ireland
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2007-06-01
- Enrollment
- 692
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.